Anti-VEGFA Neutralizing Antibody (V3S-0622-YC2785) (CAT#: V3S-0622-YC2785)

Send Inquiry
  • fig1
    Figure 1 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in WB
  • fig1
    Figure 2 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in WB
  • fig1
    Figure 3 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in DB
  • fig1
    Figure 4 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in DB
  • fig1
    Figure 5 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in ELISA
  • fig1
    Figure 6 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with VEGFA. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Immunogen Purified intact human VEGF
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; DB; FC; IP; ELISA; Neut; FuncS; IF; ICC
Application Notes The antibody is recommended for detection of VEGFA by FC, IP, ELISA, Neut, FuncS, IF, ICC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target VEGFA
Alternative Name vascular endothelial growth factor A; vascular endothelial growth factor, VEGF; VEGF A; VPF; vascular permeability factor; VEGF; MVCD1; MGC70609;
Gene ID 7422
UniProt P15692
Research Area Cardiovascular

Tested Data

WB

Figure 1 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in WB

Western blot analysis of V3S-0622-YC2785 was performed by loading Human VEGF165 Protein (His Tag) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0622-YC2785 and HRP Goat Anti-Human IgG as a secondary antibody. Chemiluminescent detection was performed.
Lane 1: Reduced antigen (0.8 μg)

Figure 1 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in WB

WB

Figure 2 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in WB

Western blot analysis of V3S-0622-YC2785 was performed by loading Human VEGF121 Protein (His Tag) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0622-YC2785 and HRP Goat Anti-Human IgG as a secondary antibody. Chemiluminescent detection was performed.
Lane 1: Reduced antigen (0.8 μg)

Figure 2 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in WB

DB

Figure 3 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in DB

Dot Blot analysis of V3S-0622-YC2785 was performed by coating with Human VEGF165 Protein (His Tag).

V3S-0622-YC2785 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-Human IgG as a secondary antibody (1: 2000)

Figure 3 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in DB

DB

Figure 4 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in DB

Dot Blot analysis of V3S-0622-YC2785 was performed by coating with Human VEGF121 Protein (His Tag).

V3S-0622-YC2785 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-Human IgG as a secondary antibody (1: 2000)

Figure 4 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in DB

ELISA

Figure 5 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in ELISA

ELISA analysis of V3S-0622-YC2785 was performed by coating with Human VEGF165 Protein (His Tag). Then blocked with BSA, and incubated with V3S-0622-YC2785. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 5 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in ELISA

ELISA

Figure 6 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in ELISA

ELISA analysis of V3S-0622-YC2785 was performed by coating with Human VEGF121 Protein (His Tag). Then blocked with BSA, and incubated with V3S-0622-YC2785. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 6 Anti-Human VEGF Monoclonal Antibody (V3S-0622-YC2785) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry